Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Drug crawled date : 2021 - 09 - 15 save search
Profile of Entasis Therapeutics ETX0462 Candidate Published in the Journal NaturePublication Details the Discovery and Preclinical Profile of ETX0462, a First-in-Class Candidate Against Multidrug-Resistant Pathogens
Published: 2021-09-15 (Crawled : 23:00) - biospace.com/
ETTX | $2.19 -0.46% 0.46%
|
Health Technology
|
| O: -0.7%
H: 2.12%
C: -3.18%
drug pathogens preclinical pre-clinical
FDA Reverses Course on NDA Submission for Amylyx ALS Drug
Published: 2021-09-15 (Crawled : 18:00) - biospace.com/
BCLI A | $0.5339 1.7% 1.67% 190K
|
Health Technology
|
| O: 1.91%
H: 18.75%
C: 10.31%
fda drug submission als
Aptorum Group Limited Has Received IND Clearance From the US FDA to Initiate Clinical Trials for Repurposed Small Molecule Drug SACT-1 for the Treatment of Neuroblastoma
Published: 2021-09-15 (Crawled : 14:00) - biospace.com/
APM | $5.69 3.45% 3.34% 17K
|
Health Technology
|
| O: 0.76%
H: 5.28%
C: 4.53%
treatment fda clinical trials trials drug repurposed trial clearance
Revolution Medicines to Participate in 3rd Annual RAS-Targeted Drug Development Summit
Published: 2021-09-15 (Crawled : 12:15) - globenewswire.com
RVMD | $35.56 -1.93% -1.97% 1.2M
|
Health Technology
|
| O: -0.34%
H: 4.55%
C: 3.97%
drug
Revolution Medicines to Participate in 3rd Annual RAS-Targeted Drug Development SummitCompany’s Scientific Leadership to Highlight Key Findings from Ongoing RAS(ON) Inhibitor Programs
Published: 2021-09-15 (Crawled : 12:15) - biospace.com/
RVMD | $35.56 -1.93% -1.97% 1.2M
|
Health Technology
|
| O: -0.34%
H: 4.55%
C: 3.97%
ongoing drug
Insights on the Advanced Dermatology Drug Delivery Devices Global Market to 2030 - Featuring AptarGroup, Bespak and Midas Pharma Among Others
Published: 2021-09-15 (Crawled : 12:00) - prnewswire.com
WST | $385.73 -1.15% 0.0% 760K
|
Health Technology
|
| O: 0.37%
H: 1.13%
C: -0.27%
BDX | $233.83 -0.23% 3.49% 780K
|
Health Technology
|
| O: 0.28%
H: 0.98%
C: 0.19%
ATR | $140.01 0.19% 0.0% 430K
|
Process Industries
|
| O: -0.55%
H: 1.23%
C: 0.59%
drug device drug delivery liver pharma
iPharma Inhalation Labs Now Supporting GMP Drug/Device Release Testing for Pulmonary Clinical Phase 1 & 2 Studies
Published: 2021-09-15 (Crawled : 12:00) - biospace.com/
NKTR | News | $1.39 -2.11% -2.16% 960K
|
Health Technology
|
| O: -0.25%
H: 3.45%
C: 1.57%
phase 1 test drug device phase 2 phase 3
ObsEva Announces Submission of New Drug Application to U.S. FDA for Linzagolix for the Treatment of Uterine Fibroids
Published: 2021-09-15 (Crawled : 06:00) - globenewswire.com
OBSV | $0.1018 -15.52% -18.95% 8.2M
|
Health Technology
|
| O: 3.32%
H: 0.96%
C: -1.61%
new drug treatment fda drug submission linzagolix application
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.